Leishmania parasites are the causative agents of leishmaniasis, a disease that affects large numbers of people over vast regions of the globe. There are two principal stages in the life cycle of these parasitic protozoa: promastigotes are slender, flagellated, extracellular organisms that live in the gut of the sandfly vector, while amastigotes are oval, non-flagellated, sessile, intracellular parasites that are specifically adapted for growth and survival within the mammalian host macrophages. Each of these two stages of the life cycle expresses a subset of stage-specific genes that confer a distinct phenotype upon that stage. The purpose of this proposal is to study the genes that encode three previously identified stage-specific proteins. The RNAs encoding two of these proteins are very abundant in the promstigote stage but are absent in amastigotes; the RNA encoding the third protein is abundant in amastigotes but absent in promastigotes. We will clone the genes encoding these three stage-specific proteins and use these cloned genes to: i) understand the molecular mechanisms responsible for repressing their expression in one life-cycle stage and inducing their expression in the other stage, and ii) probe the function of each stage-specific protein in the parasite life cycle. These studies on stage-specific gene expression will contribute to two long-term objectives: i) to understand basic features of gene expression and regulation in these parasites, phenomena which are poorly understood at present; ii) to understand how these parasites adapt to and survive within two different and potentially hostile environments, the insect gut and the host macrophage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI025920-01A1
Application #
3139604
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1988-09-01
Project End
1991-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Landfear, Scott M; Tran, Khoa D; Sanchez, Marco A (2015) Flagellar membrane proteins in kinetoplastid parasites. IUBMB Life 67:668-76
Rodriguez-Contreras, Dayana; Aslan, Hamide; Feng, Xiuhong et al. (2015) Regulation and biological function of a flagellar glucose transporter in Leishmania mexicana: a potential glucose sensor. FASEB J 29:11-24
Rodriguez-Contreras, Dayana; Landfear, Scott M (2014) Transporters, channels and receptors in flagella. Channels (Austin) 8:477-8
Tran, Khoa D; Rodriguez-Contreras, Dayana; Vieira, Danielle P et al. (2013) KHARON1 mediates flagellar targeting of a glucose transporter in Leishmania mexicana and is critical for viability of infectious intracellular amastigotes. J Biol Chem 288:22721-33
Feng, Xiuhong; Rodriguez-Contreras, Dayana; Polley, Tamsen et al. (2013) 'Transient' genetic suppression facilitates generation of hexose transporter null mutants in Leishmania mexicana. Mol Microbiol 87:412-29
Tran, Khoa D; Rodriguez-Contreras, Dayana; Shinde, Ujwal et al. (2012) Both sequence and context are important for flagellar targeting of a glucose transporter. J Cell Sci 125:3293-8
Blume, Martin; Hliscs, Marion; Rodriguez-Contreras, Dayana et al. (2011) A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs. FASEB J 25:1218-29
Vince, James E; Tull, Dedreia; Landfear, Scott et al. (2011) Lysosomal degradation of Leishmania hexose and inositol transporters is regulated in a stage-, nutrient- and ubiquitin-dependent manner. Int J Parasitol 41:791-800
Feng, Xiuhong; Feistel, Torben; Buffalo, Cosmo et al. (2011) Remodeling of protein and mRNA expression in Leishmania mexicana induced by deletion of glucose transporter genes. Mol Biochem Parasitol 175:39-48
Landfear, S M (2010) Transporters for drug delivery and as drug targets in parasitic protozoa. Clin Pharmacol Ther 87:122-5

Showing the most recent 10 out of 48 publications